105 related articles for article (PubMed ID: 26334316)
21. Prognostic factors for glioblastoma patients--a clinical population-based study.
Fekete B; Werlenius K; Örndal C; Rydenhag B
Acta Neurol Scand; 2016 Jun; 133(6):434-41. PubMed ID: 26358197
[TBL] [Abstract][Full Text] [Related]
22. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
Rong X; Yang W; Garzon-Muvdi T; Caplan JM; Hui X; Lim M; Huang J
Cancer; 2016 Oct; 122(20):3157-3165. PubMed ID: 27500668
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
24. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon RE; Halperin EC
Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme.
Hsieh PC; Chandler JP; Bhangoo S; Panagiotopoulos K; Kalapurakal JA; Marymont MH; Cozzens JW; Levy RM; Salehi S
Neurosurgery; 2005 Oct; 57(4):684-92; discussion 684-92. PubMed ID: 16239880
[TBL] [Abstract][Full Text] [Related]
26. Socioeconomic factors affecting survivorship of glioblastoma patients in the Philippines.
Hong MAC; Omar AT; Khu KJO
J Clin Neurosci; 2022 Apr; 98():89-95. PubMed ID: 35151062
[TBL] [Abstract][Full Text] [Related]
27. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
28. Primary malignant brain tumor incidence and Medicaid enrollment.
Sherwood PR; Stommel M; Murman DL; Given CW; Given BA
Neurology; 2004 May; 62(10):1788-93. PubMed ID: 15159479
[TBL] [Abstract][Full Text] [Related]
29. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
30. Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy.
Baldin E; Testoni S; de Pasqua S; Ferro S; Albani F; Baruzzi A; D'Alessandro R;
Neurol Sci; 2017 Feb; 38(2):255-262. PubMed ID: 27807698
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism (VTE) and glioblastoma.
Yust-Katz S; Mandel JJ; Wu J; Yuan Y; Webre C; Pawar TA; Lhadha HS; Gilbert MR; Armstrong TS
J Neurooncol; 2015 Aug; 124(1):87-94. PubMed ID: 25985958
[TBL] [Abstract][Full Text] [Related]
32. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
Khatri RG; Navaratne K; Weil RJ
J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
[TBL] [Abstract][Full Text] [Related]
33. Intracranial tumors in adult population of the Varazdin County (Croatia) 1996-2004: a population-based retrospective incidence study.
Dobec-Meić B; Pikija S; Cvetko D; Trkulja V; Pazanin L; Kudelić N; Rotim K; Pavlicek I; Kostanjevec AR
J Neurooncol; 2006 Jul; 78(3):303-10. PubMed ID: 16598428
[TBL] [Abstract][Full Text] [Related]
34. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
35. Experiences with reoperation on recurrent glioblastoma multiforme.
Pinsker M; Lumenta C
Zentralbl Neurochir; 2001; 62(2):43-7. PubMed ID: 11786935
[TBL] [Abstract][Full Text] [Related]
36. Incidence trends in the anatomic location of primary malignant brain tumors in the United States: 1992-2006.
Zada G; Bond AE; Wang YP; Giannotta SL; Deapen D
World Neurosurg; 2012; 77(3-4):518-24. PubMed ID: 22120376
[TBL] [Abstract][Full Text] [Related]
37. Extraneural Glioblastoma Multiforme Vertebral Metastasis.
Goodwin CR; Liang L; Abu-Bonsrah N; Hdeib A; Elder BD; Kosztowski T; Bettegowda C; Laterra J; Burger P; Sciubba DM
World Neurosurg; 2016 May; 89():578-582.e3. PubMed ID: 26704201
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
39. Glioblastoma multiforme in patients with history of extracranial cancer: Case series.
Kalita O; Trojanec R; Megova M; Hajduch M; Vaverka M; Hrabalek L; Zlevorova M; Drabek J; Tuckova L; Vrbkova J
Clin Neurol Neurosurg; 2016 May; 144():39-43. PubMed ID: 26971293
[TBL] [Abstract][Full Text] [Related]
40. Depression and glioblastoma, complicated concomitant diseases: a systemic review of published literature.
Mugge L; Mansour TR; Crippen M; Alam Y; Schroeder J
Neurosurg Rev; 2020 Apr; 43(2):497-511. PubMed ID: 30094499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
